News

Robert Yu, CEO of Yuyu Pharma, said that "The partnership with SD BIOSENSOR will help provide much needed COVID-19 Kits to medical professionals. We hope our efforts will contribute in the fight ...
The STANDARD Q antigen tests, which are different from other SD Biosensor at-home test kits, do not meet FDA standards for reliability.
The Federal Government has approved two Rapid Diagnostic Test (RDTs) kits manufactured by SD Biosensor and Abbott for COVID-19 testing. It explained that while RDTs provide a faster turnaround ...
SD Biosensor, a Korean developer of COVID-19 test kits, said Friday it has signed a deal to buy an Italian medical device distributor for 61.9 billion won ($49.8 million) in an effort to tap ...
The Federal Government has approved two Rapid Diagnostic Test (RDTs) kits manufactured by SD Biosensor and Abbott for covid-19 testing.
SD Biosensor and three other Korean companies had their first testing kits approved by the Korea Centers for Disease Control and Prevention in February 2020.
Robert Yu, CEO of Yuyu Pharma, said that "The partnership with SD BIOSENSOR will help provide much needed COVID-19 Kits to medical professionals. We hope our efforts will contribute in the fight ...
The STANDARD Q antigen tests, which are different from other SD Biosensor at-home test kits, do not meet FDA standards for reliability.
The STANDARD Q antigen tests, which are different from other SD Biosensor at-home test kits, do not meet FDA standards for reliability.
The STANDARD Q antigen tests, which are different from other SD Biosensor at-home test kits, do not meet FDA standards for reliability.
The STANDARD Q antigen tests, which are different from other SD Biosensor at-home test kits, do not meet FDA standards for reliability.